All In MedTech

Device Trial Radar · NCT05077774

Harmony TPV Post-Approval Study

Harmony TPV Post-Approval Study (Harmony PAS2)

Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

174

Actual

Start

Oct 25, 2021

Primary completion

Nov 2026

Study completion Mar 2035

Sponsor

Lead sponsor
Medtronic CardiovascularPublic (MDT)
Sponsor type
Industry
First posted
Oct 14, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (TPV) achieved by real-world implanters.

Conditions

  • Congenital Heart Disease
  • Tetrology of Fallot
  • RVOT Anomaly
  • Pulmonary Regurgitation

Interventions

  • Harmony TPV SystemDevice

    Harmony Transcatheter Pulmonary Valve (sizes 22 mm and 25 mm) and Harmony Delivery Catheter System (DCS)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects without valve reintervention and with acceptable hemodynamic function composite at 6 months as defined by:Time frame: 6 months

Locations

20 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Hospital

    Birmingham, Alabama

  • Cedars Sinai Medical Center

    Los Angeles, California

  • Children's Hospital Colorado

    Aurora, Colorado

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.